Astraea
ActiveAgents that accelerate clinical trials.
About
Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.
Founders · 2
prev Data Engineer @ Baylor College of Medicine | 4 Publications in Fetal Medicine | CS and Bio at Stanford
Previous undergraduate at Stanford studying CS and Math. Top 250 united states (USAMO) Qualifier, USACO Platinum, first intern at Salient (W23) developing enterprise systems.
Launch
Astraea is an agentic platform that automates clinical trial data analysis and statistical programming, from raw study data to CDISC-compliant datasets, TFLs, and FDA-ready outputs.
Astraea builds an AI-native platform that automates the end-to-end clinical trial biometrics pipeline, from raw data and protocol to CDISC-compliant datasets, analysis-ready variables, SAPs, and regulatory outputs. It targets oncology and rare disease studies, aiming to reduce multi-month manual work and enable submission-ready results with humans in the loop for review.
Related startups
Full stack AI Agents accelerating Biopharma R&D
Automated clinical trial oversight and execution
